Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100
زيمر بيوميت
Zimmer Biomet Holdings, Inc. ZBH | 0.00 |
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:
ZBH) with a Hold and raises the price target from $83 to $100.